-
381por Lacson, Ronilda, Pitzer, Erik, Hinske, Christian, Galante, Pedro, Ohno-Machado, Lucila“…BACKGROUND: This study describes a large-scale manual re-annotation of data samples in the Gene Expression Omnibus (GEO), using variables and values derived from the National Cancer Institute thesaurus. A framework is described for creating an annotation scheme for various diseases that is flexible, comprehensive, and scalable. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
382por Stoddart, Emily S., Senadheera, Sevvandi, MacDougall, Iain J. A., Griffith, Renate, Finch, Angela M.“…In this study four and five-feature pharmacophores for selective antagonists at each of the three α(1)-adrenoceptor (AR) subtypes were used to identify novel α(1)-AR subtype selective compounds in the National Cancer Institute and Tripos LeadQuest databases. 12 compounds were selected, based on diversity of structure, predicted high affinity and selectivity at the α(1D)- subtype compared to α(1A)- and α(1B)-ARs. 9 out of 12 of the tested compounds displayed affinity at the α(1A) and α(1D) -AR subtypes and 6 displayed affinity at all three α(1)-AR subtypes, no α(1B)-AR selective compounds were identified. 8 of the 9 compounds with α(1)-AR affinity were antagonists and one compound displayed partial agonist characteristics. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
383“…In 1992, an international workshop sponsored by the United States National Cancer Institute concluded that there was an “emerging epidemic” of NHL and emphasized the need to investigate the factors responsible for the increasing incidence of this disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
384por Parkinson, David R, Dracopoli, Nicholas, Petty, Brenda Gumbs, Compton, Carolyn, Cristofanilli, Massimo, Deisseroth, Albert, Hayes, Daniel F, Kapke, Gordon, Kumar, Prasanna, Lee, Jerry SH, Liu, Minetta C, McCormack, Robert, Mikulski, Stanislaw, Nagahara, Larry, Pantel, Klaus, Pearson-White, Sonia, Punnoose, Elizabeth A, Roadcap, Lori T, Schade, Andrew E, Scher, Howard I, Sigman, Caroline C, Kelloff, Gary J“…To that end, this review describes methods for interactive comparisons of proprietary new technologies, clinical trial designs, a clinical validation qualification strategy, and an approach for effectively carrying out this work through a public-private partnership that includes test developers, drug developers, clinical trialists, the US Food & Drug Administration (FDA) and the US National Cancer Institute (NCI).…”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
385por Seto, Belinda“…Rapamycin has proven to be a versatile compound with several seemingly unrelated properties, including antifungal, immunosuppressive, and anticancer. The National Cancer Institute (NCI) Developmental Therapeutics Program demonstrated that rapamycin inhibited cell growth in tumor cell lines. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
386por Blagosklonny, Mikhail V.“…In 2011, The National Cancer Institute (NCI) has announced 24 provocative questions on cancer. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
387por Chen, Kai, Wu, Dajiang, Zhu, Xiaodong, Ni, Haijian, Wei, Xianzhao, Mao, Ningfang, Xie, Yang, Niu, Yunfei, Li, Ming“…The gene expression profiles of 37 disc tissue samples obtained from patients with herniated discs and degenerative disc disease collected by the National Cancer Institute Cooperative Tissue Network were analyzed. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
388por Müller, Annegret, Edmonston, Tina Bocker, Dietmaier, Wolfgang, Büttner, Reinhard, Fishel, Richard, Rüschoff, Josef“…In 1997, an international collaborative workshop sponsored by the National Cancer Institute (NCI) proposed a set of guidelines for MSI-testing to improve reliability and reproducibility of the analysis as well to allow comparisons between different studies and different laboratories. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
389por Weinstein, John N.“…A case in point is the set of pharmacogenomic studies that we and our collaborators have done with the 60 human cancer cell lines of the National Cancer Institute’s drug discovery program. Those cells (the NCI-60) have been characterized pharmacologically with respect to their sensitivity to > 70,000 chemical compounds. …”
Publicado 2001
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
390por Ahsan, Mohamed Jawed, Sharma, Jyotika, Singh, Monika, Jadav, Surender Singh, Yasmin, Sabina“…The compounds were screened for anticancer activity as per National Cancer Institute (NCI US) protocol on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate, and breast cancers cell lines. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
391“…The anticancer activities were evaluated on a panel of 60 cell lines by the National Cancer Institute according to its own screening protocol. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
392por Malik, Shakun M., Pazdur, Richard, Abrams, Jeffrey S., Socinski, Mark A., Sause, William T., Harpole, David H., Welch, John J., Korn, Edward L., Ullmann, Claudio Dansky, Hirsch, Fred R.“…On February 2, 2012, the National Cancer Institute (NCI) sponsored a 2-day workshop with the NCI Thoracic Malignancies Steering Committee and the Food and Drug Administration to bring together leading academicians, clinicians, industry and government representatives to identify challenges and potential solutions in the clinical development of novel targeted therapies for lung cancer. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
393por Demyati, Eyad“…Data were collected using a validated self-administered questionnaire adopted from the National Cancer Institute in USA, customized by adding and eliminating questions to be in line with the institution (NGHA) characteristics. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
394“…ABBREVIATIONS: MTB - Mycobacterium tuberculosis, NCI - National Cancer Institute, PDB - Protein Databank.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
395por Del Ferraro, Catherine, Ferrell, Betty, Van Zyl, Carin, Freeman, Bonnie, Klein, Linda“…We also review the IOM recommendations; highlight the work done by the National Consensus Project in promoting quality PC; and discuss a National Cancer Institute–funded program project currently conducted at a National Comprehensive Cancer Center, "Palliative Care for Quality of Life and Symptoms Concerns in Lung Cancer," which serves as a model to promote high-quality care for patients and their families.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
396por Nyrop, Kirsten A., Callahan, Leigh F., Rini, Christine, Altpeter, Mary, Hackney, Betsy, Schecher, Arielle, Wilson, Anne, Muss, Hyman B.“…Our process parallels the National Cancer Institute’s Research-Tested Intervention Programs (RTIPs) guidelines for adapting evidence-based programs for cancer populations. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
397“…We used the National Cancer Institute (NCI) method to assess usual intake of 21 micronutrients and the percentage of the population under EARs and above Tolerable Upper Intake Levels (UL). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
398por Rahnama, Mansur, Madej-Czerwonka, Barbara, Jastrzębska-Jamrogiewicz, Izabela, Jamrogiewicz, Rafał“…Dental status and oral mucosa were examined using the criteria of the National Cancer Institute Toxicity Criteria Scale. The levels of stimulated and unstimulated saliva flow were analysed. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
399por Larrick, James W, Parren, Paul WHI, Huston, James S, Plückthun, Andreas, Bradbury, Andrew, Tomlinson, Ian M, Chester, Kerry A, Burton, Dennis R, Adams, Gregory P, Weiner, Louis M, Scott, Jamie K, Alfenito, Mark R, Veldman, Trudi, Reichert, Janice M“…Keynote addresses will be given by academic and industry experts Douglas Lauffenburger (Massachusetts Institute of Technology), Ira Pastan (National Cancer Institute), James Wells (University of California, San Francisco), Ian Tomlinson (GlaxoSmithKline) and Anthony Rees (Rees Consulting AB and Emeritus Professor, University of Bath). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
400por Chu, Andy, Robertson, Gordon, Brooks, Denise, Mungall, Andrew J., Birol, Inanc, Coope, Robin, Ma, Yussanne, Jones, Steven, Marra, Marco A.“…Combined with initiatives like the National Cancer Institute Genomics Cloud Pilots, such data resources will make intensive analysis of large-scale cancer genomics data widely accessible. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto